European Surgical Research

Original Paper

Vascular Endothelial Growth Factors C and D Represent Novel Prognostic Markers in Colorectal Carcinoma Using Quantitative Image Analysis

Hu W.-G.a, c · Li J.-W.a, c · Feng B.a-c · Beveridge M.e · Yue F.a-c · Lu A.-G.a, c · Ma J.-J.a-c · Wang M.-L.a, c · Guo Y.d · Jin X.-L.d · Zheng M.-H.a-c

Author affiliations

aDepartment of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, bShanghai Institute of Digestive Surgery, cShanghai Minimally Invasive Surgery Center, and dDepartment of Pathology, Ruijin Hospital, Shanghai, PR China; eOffice of International Surgery, University of Toronto, Toronto, Ont., Canada

Keywords: Colorectal neoplasmVascular endothelial factor CVascular endothelial factor DMicrovessel densityLymphangiogenesisAngiogenesisPrognosis, colorectal cancer

Related Articles for ""
Eur Surg Res 2007;39:229–238
https://doi.org/10.1159/000101855

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: November 26, 2006
Accepted: February 20, 2007
Published online: April 19, 2007
Issue release date: June 2007

Number of Print Pages: 10
Number of Figures: 6
Number of Tables: 1

ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)

For additional information: https://www.karger.com/ESR

Abstract

Background/Aims: Vascular endothelial growth factor C (VEGF-C) and vascular endothelial growth factor D (VEGF-D) are potent lymphangiogenic and angiogenetic mediators in many kinds of tumors. However, the exact impacts of VEGF-C and VEGF-D on the prognosis of colorectal cancer (CRC) remain elusive. The aims of this study were to demonstrate the expression of VEGF-C and VEGF-D and to correlate their expression levels with clinicopathological factors and long-term survival in patients with CRC. Patients and Methods: Between January 1996 and January 1998, 69 patients with pathologically confirmed CRC who received routine follow-up at the Ruijin Hospital were included in this study. VEGF-C and VEGF-D protein expression and microvessel density of 69 surgical specimens were assessed by immunohistochemistry, with 20 samples of normal colorectal tissues as controls. All patients were followed up for 108 months or until death. The Immunohistochemical stains were quantified and analyzed by means of a Zeiss Axioplan 2 imaging analysis system. Results: The protein expression of VEGF-C and VEGF-D in tumor tissues was much higher than that in normal colorectal tissues (p < 0.01). The VEGF-C expression significantly correlated with lymph node metastasis (p = 0.011) and clinical stages of CRC (p < 0.01). The VEGF-D expression correlated with patient ages (p = 0.013), depth of tumor invasion (p = 0.013), and lymph node metastasis (p = 0.028). The expression of VEGF-C and VEGF-D was significantly correlated with the microvessel density. Both overall survival and disease-free survival at 108 months were significantly lower in the CRC patients with a high VEGF-C and/or a high VEGF-D expression, and the patients with a high expression of both VEGF-C and VEGF-D had the shortest overall survival and disease-free survival when compared with other patients. Conclusion: The VEGF-C or VEGF-D expression was significantly correlated with lymph node metastasis and long-term prognosis and could be applied as prognostic markers in CRC.

© 2007 S. Karger AG, Basel



Related Articles:

References

  1. Jemal A, Thomas A, Murray T, et al: Cancer statistics, 2002. CA Cancer J Clin 2002;52:23–47.
    External Resources
  2. Feng B, Zheng MH, Zheng YF, et al: The normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring. J Gastroenterol Hepatol 2005;20:1913–1919.
    External Resources
  3. Feng B, Zheng MH, Ma JJ, et al: Clinical significance of human kallikrein gene 10 expression in colorectal cancer and gastric cancer. J Gastroenterol Hepatol 2006;21:1596–1603.
    External Resources
  4. Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571–573.
    External Resources
  5. Fidler IJ: The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 2003;3:453–458.
    External Resources
  6. Stacker SA, Achen MG, Jussila L, et al: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573–583.
    External Resources
  7. Stacker SA, Baldwin ME, Achen MG: The role of tumor lymphangiogenesis in metastatic spread. FASEB J 2002;16:922–934.
    External Resources
  8. Beahrs OH, Myers MH: Purposes and principles of staging; in: Manual for Staging of Cancer. Philadelphia, Lippincott, 1983, pp 3–5.
  9. Tomisaki S, Ohno S, Ichiyoshi Y, et al: Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 1996;77(suppl 8):1722–1728.
  10. Karpanen T, Egeblad M, Karkkainen MJ, et al: Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001;61:1786–1790.
    External Resources
  11. Mandriota SJ, Jussila L, Jeltsch M, et al: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001;20:672–682.
    External Resources
  12. Skobe M, Hawighorst T, Jackson DG, et al: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192–198.
    External Resources
  13. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9–19.
    External Resources
  14. Maier CM, Hsieh L, Yu F, et al: Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia. Stroke 2004;35:1169–1174.
    External Resources
  15. Witkiewicz AK, Varambally S, Shen R, et al: Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis. Cancer Epidemiol Biomarkers Prev 2005;14:1418–1423.
    External Resources
  16. White JD, Hewett PW, Kosuge D, et al: Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 2002;62:1669–1675.
    External Resources
  17. Stacker SA, Achen MG: The vascular endothelial growth factor family: signaling for vascular development. Growth Factors 1999;17:1–11.
    External Resources
  18. Joukov V, Pajusola K, Kaipainen A, et al: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290–298.
    External Resources
  19. Achen MG, Jeltsch M, Kukk E, et al: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4). Proc Natl Acad Sci USA 1998;95:548–553.
    External Resources
  20. Kaipainen A, Korhonen J, Mustonen T, et al: Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995;92:3566–3570.
    External Resources
  21. Veikkola T, Jussila L, Makinen T, et al: Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 2001;20:1223–1231.
    External Resources
  22. Jeltsch M, Kaipainen A, Joukov V, et al: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276:1423–1425.
    External Resources
  23. Oh S, Jeltsch M, Birkenhager R, et al: VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997;188:96–109.
    External Resources
  24. Karkkainen MJ, Haiko P, Sainio K, et al: Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004;5:74–80.
    External Resources
  25. Skobe M, Hamberg LM, Hawighorst T, et al: Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001;159:893–903.
    External Resources
  26. Kitadai Y, Kodama M, Cho S, et al: Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer 2005;115:388–392.
    External Resources
  27. Endreseth BH, Romundstad P, Myrvold HE, et al: Rectal cancer in the young patient. Dis Colon Rectum 2006;49:993–1001.
    External Resources
  28. Lin JT, Wang WS, Yen CC, et al: Outcome of colorectal carcinoma in patients under 40 years of age. J Gastroenterol Hepatol 2005;20:900–905.
    External Resources
  29. Vermeulen PB, Van den Eynden GG, Huget P, et al: Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer 1999;79:316–322.
    External Resources
  30. Banner BF, Whitehouse R, Baker SP, et al: Tumor angiogenesis in stage II colorectal carcinoma: association with survival. Am J Clin Pathol 1998;109:733–737.
    External Resources
  31. Lindmark G, Gerdin B, Sunberg C, et al: Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol 1996;14:461–466.
    External Resources
  32. Onogawa S, Kitadai Y, Tanaka S, et al: Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 2004;95:32–39.
    External Resources
  33. White JD, Hewett PW, Kosuge D, et al: Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 2002;62:1669–1675.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: November 26, 2006
Accepted: February 20, 2007
Published online: April 19, 2007
Issue release date: June 2007

Number of Print Pages: 10
Number of Figures: 6
Number of Tables: 1

ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)

For additional information: https://www.karger.com/ESR

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2007, Vol.39, No. 4

June 2007

Article

Recommend This
TOP